Stockreport

Correction: Nkarta Reports Second Quarter 2024 Financial Results and Corporate Highlights [Yahoo! Finance]

Nkarta, Inc.  (NKTX) 
PDF Preliminary clinical data from Ntrust-1 and Ntrust-2 clinical trials planned for 2025 Cash balance of $426.7 million on June 30, 2024, including cash, cash equivalent [Read more]